SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as investors debate the potential of its evolving business model and capital allocation strategy, with the community polarized between frustration over recent price performance and optimism about its cash-heavy balance sheet. While vocal bears point to consecutive lows and store closures, loyalists remain focused on potential M&A activity and the shifting revenue mix toward collectibles as key drivers for a future turnaround.

WhiteFiber, Inc. provides AI and HPC infrastructure & cloud and data center solutions. It operates through the following segments: Cloud Services and Colocation Services. The Cloud Services segment offers computing services to support generative AI workstreams. The Colocation Services segment provides customers with physical space, power and cooling within the data center facility. The company was founded on August 15, 2024 and is headquartered in New York, NY.

Whitefiber Inc.

WhiteFiber, Inc.

WhiteFiber, Inc. (WYFI) is experiencing significant downward pressure following the company's announcement of a $250 million private placement of convertible senior notes, which has triggered widespread investor concerns regarding share dilution. The stock's sharp decline has sparked heated debate in the community, with some investors accusing the company of market manipulation and poor management, while others view the pullback as a buying opportunity based on the company's data center expansion plans and long-term revenue potential.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is trending as traders react to a significant new satellite infrastructure contract that has bolstered the company's backlog and sparked discussions about its role as a key space sector prime contractor. Community sentiment is deeply divided, with bulls pointing to the company's growth and commercial momentum while bears express concerns over high volatility, valuation, and the potential for dilution.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is trending due to heightened volatility and concerns over aggressive at-the-market equity offerings, which investors are debating as a dilution risk versus a strategic play to stabilize debt and preferred stock. The community remains deeply divided, with bears pointing to MSCI exclusion risks and persistent selling pressure, while bulls frame the current price action as a key accumulation zone ahead of a potential Bitcoin cycle breakout.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is facing significant downward pressure as investors react to a downward revision in full-year guidance and the news that the company’s CFO and CMO will be stepping down. While some in the community view the sell-off as an overreaction and a buying opportunity, others remain skeptical about the firm’s ability to manage credit risks in the current macro environment.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehr Test Systems is seeing high volatility and intense social media debate as traders clash over its AI-driven growth thesis versus its lofty valuation and recent insider selling. The stock remains a major focal point for traders tracking semiconductor capex and wafer-level testing demand, with bullish momentum driven by repeat production orders pitted against bearish concerns regarding potential share dilution and unsustainable price-to-sales ratios.

Amylyx Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of therapies for diseases with significant unmet medical need, with an emphasis on endocrine and neurodegenerative disorders. Its program, avexitide, is a once-daily GLP-1 receptor antagonist being developed for the treatment of post-bariatric hypoglycemia. Amylyx’s pipeline also includes investigational programs targeting Wolfram syndrome and amyotrophic lateral sclerosis (ALS). The company was founded by Joshua Cohen and Justin Klee in 2013 and is headquartered in Cambridge, MA.

Amylyx Pharmaceuticals Inc

Amylyx Pharmaceuticals is trending following positive Phase 3 LUCIDITY trial results for avexitide in post-bariatric hypoglycemia, which significantly exceeded expectations and met all endpoints. While the news sparked an aggressive rally and analyst upgrades, the stock remains a focal point for debate as investors weigh the potential for a transformative commercial launch against the immediate impact of a massive common stock offering.

VS Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

Investors are actively debating the role of UVIX as a volatility hedge amidst geopolitical tensions and growing concerns over debt and potential stagflation. The community remains divided, with some betting on a major breakout driven by market fragility, while others highlight the product's inherent long-term decay and the risks associated with its upcoming reverse split.

The Home Depot, Inc. engages in the sale of building materials and home improvement products. Its products include building materials, home improvement products, lawn and garden products and décor products. The firm operates through the following geographical segments: U.S., Canada and Mexico. It offers home improvement installation services, and tool and rental equipment. The company was founded by Bernard Marcus, Arthur M. Blank, Kenneth Gerald Langone and Pat Farrah on June 29, 1978 and is headquartered at Atlanta, GA.

Home Depot, Inc.

Home Depot is trending as investors weigh a fiscal Q1 earnings beat against ongoing concerns regarding a frozen housing market and soft consumer demand for large-scale renovation projects. While the company reaffirmed its full-year guidance and reported modest growth in comparable sales, community discussions remain divided between those viewing the stock as an undervalued long-term dividend play and bears focused on the broader macro headwinds pressuring the sector.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

The bond market is facing intense downward pressure as Treasury yields surge to multi-decade highs, driven by investor anxiety over persistent inflation, rising government deficits, and institutional hedging. Community discussion is heavily divided between those seeking long-term entry points into long-duration bonds and those warning of a structural regime change where mounting debt and geopolitical risks make traditional safe-haven assets increasingly volatile.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

What Makes Lexeo Therapeutics (LXEO) One of The Best Stocks Under $10 That Could Triple

What Makes Lexeo Therapeutics (LXEO) One of The Best Stocks Under $10 That Could Triple...

Why Is Lexeo Therapeutics Stock Gaining Monday?

Lexeo Therapeutics stock jumps as LX2006 pivotal trial moves forward, with SUNRISE-FA 2 enrollment set to begin in June 2026.read more...

Lexeo Therapeutics (LXEO) Expected to Announce Quarterly Earnings on Monday

Lexeo Therapeutics (NASDAQ:LXEO) will be releasing its Q1 2026 earnings before the market opens on Monday, May 11. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-11-lexeo-therapeutics-inc-stock...

Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Given Average Rating of "Moderate Buy" by Brokerages

Lexeo Therapeutics, Inc. (NASDAQ:LXEO - Get Free Report) has received a consensus rating of "Moderate Buy" from the nine research firms that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, seven have assigned a buy rating and one...

Lexeo Therapeutics (NASDAQ:LXEO) Lowered to "Sell" Rating by Wall Street Zen

Wall Street Zen cut Lexeo Therapeutics from a "hold" rating to a "sell" rating in a research note on Saturday...

Lexeo Therapeutics (NASDAQ:LXEO) Stock Price Up 3.2%  - Should You Buy?

Lexeo Therapeutics (NASDAQ:LXEO) Stock Price Up 3.2% - Here's What Happened...

Lexeo Therapeutics (NASDAQ:LXEO) CEO Sells $312,950.00 in Stock

Lexeo Therapeutics, Inc. (NASDAQ:LXEO - Get Free Report) CEO Richard Nolan Townsend sold 55,000 shares of the company's stock in a transaction on Monday, April 6th. The stock was sold at an average...

Insider Selling: Lexeo Therapeutics (NASDAQ:LXEO) CEO Sells 55,000 Shares of Stock

Lexeo Therapeutics, Inc. (NASDAQ:LXEO - Get Free Report) CEO Richard Nolan Townsend sold 55,000 shares of the firm's stock in a transaction dated Monday, April 6th. The shares were sold at an average...

Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Shares of Lexeo Therapeutics, Inc. (NASDAQ:LXEO - Get Free Report) have received an average rating of "Moderate Buy" from the nine analysts that are presently covering the stock, MarketBeat.com...

Lexeo Therapeutics (NASDAQ:LXEO) Issues Quarterly Earnings Results

Lexeo Therapeutics (NASDAQ:LXEO - Get Free Report) issued its quarterly earnings results on Monday. The company reported ($0.29) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.32) by $0.03...

Lexeo Therapeutics, Inc. is a clinical stage genetic medicine company, which engages in the development of therapies for hereditary and acquired diseases. The firm focuses on the medication of genetically defined cardiovascular diseases and sub-group of Alzheimer’s disease. It offers LX2006 for the treatment of patients with Friedreich's ataxia, cardiomyopathy, and LX1001 for APOE4 homozygous patients with Alzheimer's disease. The company was founded by Ronald G. Crystal in February 2017 and is headquartered in New York, NY.

Lexeo Therapeutics Inc.

Lexeo Therapeutics Stock Hits 11-Month High On Bullish Analyst Calls For Friedreich’s Ataxia Gene Therapy — Retail Traders Join In

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

LXEOLexeo Therapeutics Inc.

Fundamentals

Connect Stocktwits to ChatGPT

Latest LXEO News